Richard Brian Gaynor's most recent trade in Zai Lab Limited - ADR was a trade of 1,736 American Depositary Shares done at an average price of $19.1 . Disclosure was reported to the exchange on July 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Zai Lab Ltd (ADR) | Richard Brian Gaynor | Director | Purchase of securities on an exchange or from another person at price $ 19.05 per share. | 01 Jul 2026 | 1,736 | 80,737 (0%) | 0% | 19.1 | 33,071 | American Depositary Shares |
| Zai Lab Ltd (ADR) | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 22,371 | 79,001 (0%) | 0% | 0 | American Depositary Shares | |
| Alkermes PLC | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 11,538 | 11,538 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes PLC | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2026 | 5,409 | 5,409 | - | - | Restricted Stock Unit Award | |
| Zai Lab Ltd (ADR) | Richard Brian Gaynor | Director | Purchase of securities on an exchange or from another person at price $ 18.91 per share. | 17 Mar 2026 | 1,731 | 56,630 (0%) | 0% | 18.9 | 32,733 | American Depositary Shares |
| Zai Lab Ltd (ADR) | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 10,831 | 54,899 (0%) | 0% | 0 | American Depositary Shares | |
| Alkermes PLC | Richard Brian Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 0 | - | - | Restricted Stock Unit Award | |
| Alkermes PLC | Richard Brian Gaynor | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2025 | 8,013 | 33,008 (0%) | 0% | - | Ordinary Shares | |
| Alkermes PLC | Richard Brian Gaynor | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.61 per share. | 31 May 2025 | 1,924 | 31,084 (0%) | 0% | 30.6 | 58,894 | Ordinary Shares |
| Alkermes PLC | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 13,474 | 13,474 | - | - | Non Qualified Stock Option (Right to Buy) | |
| Alkermes PLC | Richard Brian Gaynor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 6,142 | 6,142 | - | - | Restricted Stock Unit Award | |
| Zai Lab Ltd (ADR) | Richard Brian Gaynor | Director | Sale of securities on an exchange or to another person at price $ 35.07 per share. | 05 Mar 2025 | 2,500 | 44,068 (0%) | 0% | 35.1 | 87,675 | American Depositary Shares |